Financials

  • Market Capitalization 773.16 M
  • Employee 13
  • Founded 2020
  • CEO N/A
  • Website www.nuvectis.com
  • Headquarter Delaware, United States
  • FIGI BBG012BCR149
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2604
FDMT
4D Molecular Therapeutics, Inc. - Common Stock
14.67 USD-1.61%-6.44%+49.85%+29.82%810.43 M USD
2615
DBVT
DBV Technologies S.A. - American Depositary Shares
13.54 USD-6.04%-5.18%+0.67%+42.98%801.73 M USD
2643
AURA
Aura Biosciences, Inc. - Common Stock
7.40 USD-3.90%-5.13%+5.56%+18.40%767.42 M USD
2657
MNPR
Monopar Therapeutics Inc. - Common Stock
111.89 USD-1.80%+4.60%+3.63%+104.85%751.02 M USD

Frequently asked questions about Nuvectis Pharma, Inc. Common Stock

What is the Nuvectis Pharma, Inc. Common Stock stock price today?

The current price of Nuvectis Pharma, Inc. Common Stock (NVCT) is 23.73. Over the past 24 hours, the stock has changed by -5.80%. Follow the NVCT chart for real-time price dynamics.

What is the stock ticker of Nuvectis Pharma, Inc. Common Stock?

Nuvectis Pharma, Inc. Common Stock trades under the ticker NVCT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Nuvectis Pharma, Inc. Common Stock stock going up?

NVCT has changed by +0.72% over the last week, +12.52% over the last month, and +265.08% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Nuvectis Pharma, Inc. Common Stock?

Nuvectis Pharma, Inc. Common Stock currently has a market capitalization of 773.16 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Nuvectis Pharma, Inc. Common Stock earnings last quarter?

Last quarter, Nuvectis Pharma, Inc. Common Stock reported earnings of -0.3 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Nuvectis Pharma, Inc. Common Stock net income for the last quarter?

Nuvectis Pharma, Inc. Common Stock reported net income of -7.02 M for the last quarter. The previous quarter showed -6.05 M, which means net income changed by -16.03%.

How many employees does Nuvectis Pharma, Inc. Common Stock have?

As of the latest available data, Nuvectis Pharma, Inc. Common Stock has 13 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Nuvectis Pharma, Inc. Common Stock stock?

You can buy Nuvectis Pharma, Inc. Common Stock (NVCT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Nuvectis Pharma, Inc. Common Stock stock?

Investing in Nuvectis Pharma, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NVCT chart and related analysis on metatrader.com as part of your research.

News